Our lab has pioneered the development of programmable biomaterials using nucleic acids (e.g. aptamers) and hydrogels to mimic the functionality of live cells or tissues that can undergo multiple, dynamic and controllable changes on demand. These biomaterials are currently under rigorous development for drug delivery, tissue engineering, regenerative medicine, cancer immunotherapy, and stem cell therapy. You are welcome to join us to push these novel biomaterials to the next frontier.